Additionally, detection of IgA antibodies against the EBV early antigen in sera was demonstrated to be a strong indicator of NPC [6, 9]; whether its combination with IgA-gH/gL could achieve a better diagnostic outcome warrants further exploration. Here, CD79A is linked to nasopharyngeal carcinoma.